391 related articles for article (PubMed ID: 32474491)
1. An overview of pulmonary infections due to rapidly growing mycobacteria in South Asia and impressions from a subtropical region.
Shrivastava K; Kumar C; Singh A; Narang A; Giri A; Sharma NK; Gupta S; Chauhan V; Gunasekaran J; Balasubramanian V; Chaudhry A; Singla R; Prasad R; Varma-Basil M
Int J Mycobacteriol; 2020; 9(1):62-70. PubMed ID: 32474491
[TBL] [Abstract][Full Text] [Related]
2. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.
Kumar C; Shrivastava K; Singh A; Chauhan V; Varma-Basil M
Int J Mycobacteriol; 2021; 10(3):293-300. PubMed ID: 34494569
[TBL] [Abstract][Full Text] [Related]
3. Identification of non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study.
Ahmed I; Jabeen K; Hasan R
BMC Infect Dis; 2013 Oct; 13():493. PubMed ID: 24148198
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Özkarataş MH; Arslan N; Esen N; Özkütük AA
Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region.
Wani SR; Wattal C; Raveendran R
Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
Hershko Y; Adler A
Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
[TBL] [Abstract][Full Text] [Related]
8. The treatment of rapidly growing mycobacterial infections.
Kasperbauer SH; De Groote MA
Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
11. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
[TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia.
Simons S; van Ingen J; Hsueh PR; Van Hung N; Dekhuijzen PN; Boeree MJ; van Soolingen D
Emerg Infect Dis; 2011 Mar; 17(3):343-9. PubMed ID: 21392422
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
15.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
[TBL] [Abstract][Full Text] [Related]
16. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Sharma M; Malhotra B; Khandelwal S
Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
[TBL] [Abstract][Full Text] [Related]
17. Laboratory aspects of clinically significant rapidly growing mycobacteria.
Set R; Shastri J
Indian J Med Microbiol; 2011; 29(4):343-52. PubMed ID: 22120792
[TBL] [Abstract][Full Text] [Related]
18.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
19. [Frequency and clinical relevance of rapidly growing mycobacterium isolated from respiratory samples].
Duan HF; Wang QF; Wang J; Wang J; Huang HR; Chu NH
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):113-6. PubMed ID: 26879615
[TBL] [Abstract][Full Text] [Related]
20. A laboratory-based analysis of rapidly growing mycobacteria in Northwest Paulista, Sao Paulo, Brazil.
Silveira Paro Pedro HD; Tonelli Nardi SM; Ule Belotti NC; Tegon de Freitas AC; de Souza NG; Chimara E
Int J Mycobacteriol; 2021; 10(2):170-176. PubMed ID: 34558470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
